Atwood Oceanics (ATW) 7.97 $ATW Shares of ATW Down 28.1%

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Atwood Oceanics (ATW) 7.97 $ATW

Shares of ATW Down 28.1% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Fri Sep 02, 1:09AM CDT
SmarTrend identified a Downtrend for Atwood Oceanics (NYSE:ATW) on July 29th, 2016 at $10.62. In approximately 1 month, Atwood Oceanics has returned 28.06% as of today's recent price of $7.64.
ATW: 7.97 (+0.33)

ATWOOD OCEANICS TO PRESENT AT THE BARCLAYS CEO ENERGY-POWER CONFERENCE
Globe Newswire - Mon Aug 29, 3:37PM CDT
FOR IMMEDIATE RELEASE
ATW: 7.97 (+0.33)

Atwood Oceanics Down 24.2% Since SmarTrend Downtrend Call (ATW)
Comtex SmarTrend(R) - Thu Aug 25, 1:53PM CDT
SmarTrend identified a Downtrend for Atwood Oceanics (NYSE:ATW) on July 29th, 2016 at $10.62. In approximately 4 weeks, Atwood Oceanics has returned 24.21% as of today's recent price of $8.05.
ATW: 7.97 (+0.33)

Atwood Oceanics Falls 4.08% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Mon Aug 22, 3:40PM CDT
Atwood Oceanics (NYSE:ATW) traded in a range yesterday that spanned from a low of $8.35 to a high of $8.59. Yesterday, the shares fell 4.1%, which took the trading range below the 3-day low of $8.40 on volume of 2.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ATW: 7.97 (+0.33)

Watch for Atwood Oceanics to Potentially Rebound After Falling 4.08% Yesterday
Comtex SmarTrend(R) - Mon Aug 22, 3:38PM CDT
Atwood Oceanics (NYSE:ATW) traded in a range yesterday that spanned from a low of $8.35 to a high of $8.59. Yesterday, the shares fell 4.1%, which took the trading range below the 3-day low of $8.40 on volume of 2.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ATW: 7.97 (+0.33)

After Yesterday's Decline of 5.69%, Atwood Oceanics Offers Investors Better Value
Comtex SmarTrend(R) - Tue Aug 16, 4:25PM CDT
Atwood Oceanics (NYSE:ATW) traded in a range yesterday that spanned from a low of $8.76 to a high of $9.37. Yesterday, the shares fell 5.7%, which took the trading range below the 3-day low of $9.17 on volume of 2.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ATW: 7.97 (+0.33)

SmarTrend Watching for Potential Rebound in Shares of Atwood Oceanics After 5.69% Loss
Comtex SmarTrend(R) - Tue Aug 16, 4:24PM CDT
Atwood Oceanics (NYSE:ATW) traded in a range yesterday that spanned from a low of $8.76 to a high of $9.37. Yesterday, the shares fell 5.7%, which took the trading range below the 3-day low of $9.17 on volume of 2.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ATW: 7.97 (+0.33)

Post Earnings Coverage as Atwood Tops Market Expectations
ACCESSWIRE - Wed Aug 03, 8:16AM CDT
LONDON, UK / ACCESSWIRE / August 3, 2016 / Active Wall St. announces its post-earnings coverage on Atwood Oceanics Inc. (NYSE: ATW). The company announced its third quarter fiscal 2016 results after market close on August 01, 2016. The offshore drilling company reported earnings above Wall Street's expectations. Atwood Oceanics also announced the purchase of $145.8 million of its senior notes on an average discount of 34.8%. Register with us now for your free membership at: http://www.activewallst.com/register/.
NBL: 34.25 (+0.40), KOS: 6.15 (+0.08), ATW: 7.97 (+0.33)

Atwood Oceanics Announces Fiscal 2016 Third Quarter Earnings
Globe Newswire - Mon Aug 01, 3:42PM CDT
FOR IMMEDIATE RELEASE - EARNINGS
ATW: 7.97 (+0.33)

What's in Store for Oil Drilling Earnings on Aug 1: ATW, DO
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 8:34AM CDT
Drilling activities were weak as revealed by the U.S. rig count that fell to record lows. However, the operating scenario was suitable for drillers due to sequential crude recovery.
DO: 16.28 (-0.23), ATW: 7.97 (+0.33)

Atwood Oceanics Shares Up 87.8% Since SmarTrend's Buy Recommendation (ATW)
Comtex SmarTrend(R) - Thu Jun 23, 12:40PM CDT
SmarTrend identified an Uptrend for Atwood Oceanics (NYSE:ATW) on February 22nd, 2016 at $7.00. In approximately 4 months, Atwood Oceanics has returned 87.85% as of today's recent price of $13.14.
ATW: 7.97 (+0.33)

ATWOOD OCEANICS TO PRESENT AT THE 2016 WELLS FARGO WEST COAST ENERGY CONFERENCE
Globe Newswire - Fri Jun 17, 11:40AM CDT
FOR IMMEDIATE RELEASE
WFC: 50.55 (+0.12), ATW: 7.97 (+0.33)

Downgrade Alert for Atwood Oceanics (ATW)
Comtex SmarTrend(R) - Tue Jun 14, 3:01AM CDT
Atwood Oceanics (NYSE:ATW) was downgraded from Buy to Hold at Johnson Rice today. The stock closed yesterday at $11.44 on volume of 3.0 million shares, below average daily volume of 4.4 million. Atwood Oceanics has overhead space with shares priced $11.44, or 39.3% below the average consensus analyst price target of $18.83. The stock should find resistance at its 200-day moving average (MA) of $12.83, as well as support at its 50-day MA of $8.77.
ATW: 7.97 (+0.33)

Oil & Gas Drilling & Exploration Stocks Under Review -- Nabors Industries, Atwood Oceanics, Rowan Cos., and Rex Energy
PR Newswire - Fri Jun 10, 6:35AM CDT
On Thursday, June 09, 2016, the NASDAQ Composite ended the trading session at 4,958.62, down 0.32%; the Dow Jones Industrial Average edged 0.11% lower to finish at 17,985.19; and the S&P 500 closed at 2,115.48, down 0.17%. ActiveWallSt.com has initiated coverage on the following equities: Nabors Industries Ltd (NYSE: NBR), Atwood Oceanics Inc. (NYSE: ATW), Rowan Companies PLC (NYSE: RDC), and Rex Energy Corporation (NASDAQ: REXX). Learn more about these stocks by accessing their free trade alerts at:
NBR: 10.14 (+0.24), REXX: 0.56 (unch), RDC: 12.65 (+0.16), ATW: 7.97 (+0.33)

ATWOOD OCEANICS TO PRESENT AT THE BARCLAYS HIGH YIELD BOND CONFERENCE
Globe Newswire - Wed Jun 08, 3:03PM CDT
FOR IMMEDIATE RELEASE
ATW: 7.97 (+0.33)

Atwood Oceanics Shares Up 76.7% Since SmarTrend's Buy Recommendation (ATW)
Comtex SmarTrend(R) - Wed Jun 08, 12:41PM CDT
SmarTrend identified an Uptrend for Atwood Oceanics (NYSE:ATW) on February 22nd, 2016 at $7.00. In approximately 4 months, Atwood Oceanics has returned 76.70% as of today's recent price of $12.36.
ATW: 7.97 (+0.33)

Upgrade Alert for Atwood Oceanics (ATW)
Comtex SmarTrend(R) - Wed Jun 01, 3:02AM CDT
Atwood Oceanics (NYSE:ATW) was upgraded from Accumulate to Buy at KLR Group today. The stock closed yesterday at $10.67 on volume of 3.8 million shares, below average daily volume of 4.4 million. Atwood Oceanics share prices have moved between a 52-week high of $35.66 and a 52-week low of $4.82 and closed yesterday at 121% above that low price at $10.67 per share. Over the past week, the 200-day moving average (MA) has gone down 2.1% while the 50-day MA has advanced 2.2%.
ATW: 7.97 (+0.33)

Atwood Oceanics Up 52.5% Since SmarTrend Uptrend Call (ATW)
Comtex SmarTrend(R) - Wed Jun 01, 12:21AM CDT
SmarTrend identified an Uptrend for Atwood Oceanics (NYSE:ATW) on February 22nd, 2016 at $7.00. In approximately 3 months, Atwood Oceanics has returned 52.54% as of today's recent price of $10.67.
ATW: 7.97 (+0.33)

Look for Shares of Atwood Oceanics to Potentially Rebound after Yesterday's 2.09% Sell Off
Comtex SmarTrend(R) - Fri May 27, 2:31PM CDT
Atwood Oceanics (NYSE:ATW) traded in a range yesterday that spanned from a low of $10.24 to a high of $10.74. Yesterday, the shares fell 2.1%, which took the trading range below the 3-day low of $10.36 on volume of 1.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ATW: 7.97 (+0.33)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 454

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 59

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 387

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 283

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 162

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 493

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Midea's R290 Tech: Real Green Cooling Revolution?

Updated Category News Views 66

A Fresh Breeze in Sustainable Cooling In the middle of Kigali’s innovation oasis, Midea RAC stood out at MOP38, the 38th Meeting of the Parties to the Montreal Protocol, flexing its sustainable tech muscles. We're talking about their R290 air conditioning technology—a natural refrigerant with zero ozone footprint and a global warming potential of a mere three. This is...

Continue Reading
Ampace Focuses on Battery Safety Standards at RE+ 2026

Updated Category News Views 77

Battery Safety Takes Center Stage No mystery here: the safety of our beloved lithium-ion batteries is crucial, especially as AI data centers sprout like weeds. At RE+ 2026, Ampace is putting its chips on the table by spotlighting this hot topic. Dr. Drew Feng, their Chief Safety Officer, is set to reveal the big guns: findings from the PU100 large-scale fire test. Mark...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 421

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 304

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading

Top 5 Most Recently Viewed Articles

Ventas to Showcase Investment Strategy at Real Estate Conference

Updated Category News Views 44

Ventas Engages Investors at Upcoming Conference Ventas, Inc. (NYSE: VTR) is gearing up to take part in significant investor meetings at the BofA Securities 2024 Global Real Estate Conference. This event presents a valuable chance for the company to connect with investors and share insights about its strategic direction and business model. Event Details and Participation...

Continue Reading
BioLineRx Explores Synergy in Ovarian Cancer Treatment

Updated Category News Views 151

New Hope on the Ovarian Cancer Front Every so often, something comes along and makes you stop and think—could this be the game-changer in the making? Well, what BioLineRx Ltd. (NASDAQ: BLRX) and Hemispherian AS just dropped at the ESMO 2026 feels a bit like that silver lining for folks fighting the uphill battle against homologous recombination (HR)-proficient ovarian...

Continue Reading
Analyst Ratings Show Confidence in Datadog and Others

Updated Category News Views 80

Recent Upgrades by Top Analysts Leading financial analysts from Wall Street have adjusted their outlooks on several prominent companies, reflecting a more optimistic market sentiment. Upgrades often signify increased confidence in a company's performance and present potential investment opportunities for savvy investors. Here, we delve into some of the standout upgrades...

Continue Reading
Unpacking the Increased Short Interest in Ventas (NYSE: VTR)

Updated Category News Views 77

Understanding Ventas's Short Interest Surge Ventas recently recorded an uptick in its short percent of float, which now stands at 25.59% since the last report. This notable development means that 9.80 million shares are currently sold short, translating to 3.19% of all regular shares available for trading. Given the trading volume, it would take traders approximately 3.33...

Continue Reading
Precigen's PAPZIMEOS: 7-Year Exclusivity & Long-Term Success

Updated Category News Views 54

Precigen's Game-Changer: PAPZIMEOS Secures Seven-Year Exclusivity Here's how you carve out a solid niche in the biotech world: deliver some killer results and snag yourself seven years in the driver’s seat. That's exactly what Precigen (NASDAQ: PGEN) has done with their PAPZIMEOS therapy, which got the stamp of approval from the FDA as the first exclusive treatment for...

Continue Reading